Trademark: 75187094
Word
REVIA NALTREXONE HCI
Status
Dead
Status Code
710
Status Date
Saturday, March 12, 2005
Serial Number
75187094
Registration Number
2163346
Registration Date
Tuesday, June 9, 1998
Mark Type
3T17
Filing Date
Thursday, October 24, 1996
Published for Opposition
Tuesday, March 17, 1998
Cancellation Date
Saturday, March 12, 2005
Trademark Owner History
DuPont Merck Pharmaceutical Company, The - Original Registrant
Classifications
42 providing information and brochures to physicians and healthcare personnel to assist in counseling patients as part of a comprehensive treatment program for alcohol dependence
"NALTREXONE HCI"
The mark consists of a sphere superimposed on a diamond shaped background and includes Applicant's registered trademark "REVIA", No. 1,945,277, and the word "NALTREXONE HCI".
The drawing is lined for the colors green and brown. The stippling is for shading purposes only and does not indicate color.
Trademark Events
Mar 12, 2005
Cancelled Sec. 8 (6-Yr)
Jul 24, 2002
Teas Change Of Correspondence Received
Jun 9, 1998
Registered-Principal Register
Mar 17, 1998
Published For Opposition
Feb 13, 1998
Notice Of Publication
Jul 14, 1997
Approved For Pub - Principal Register
Jun 30, 1997
Assigned To Examiner
Jun 30, 1997
Assigned To Examiner
INTERNET BUSINESS OPPORTUNITIES
YES. IT'S THAT GOOD
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov